Skip to content

Clinical trials

Phase 2 Carcinoma, Renal Cell trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Phase: Phase 2 Country / region: United States Clear all

372 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200011
200112
200212
200314
200423
200523
200626
200722
200817
200910
201010
201114
20127
20136
20146
20156
20168
201714
201817
201914
202011
20214
202211
202312
20247
202512
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed189
Terminated75
Recruiting40
Active, not recruiting35
Unknown status17
Withdrawn9
Not yet recruiting4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)56
M.D. Anderson Cancer Center31
Memorial Sloan Kettering Cancer Center14
Case Comprehensive Cancer Center10
City of Hope Medical Center7
Pfizer7
Bayer6
Eastern Cooperative Oncology Group5
Emory University5
Mayo Clinic5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell372
Kidney Neoplasms151
Neoplasm Metastasis39
Melanoma35
Carcinoma, Non-Small-Cell Lung24
Neoplasms24
Breast Neoplasms11
Colorectal Neoplasms11
Carcinoma, Hepatocellular10
Pancreatic Neoplasms9

Trials

Showing 1 to 25 of 372. Each trial links to its page on Pharma Observatory.

272 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.